Jianping Chen
Impact in
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 2
-
- Glycosylation and Glycoproteins Research 1
- Heat shock proteins research 1
- Co-authors
- Xiaoping Liu (1 shared paper)Ning Li (1 shared paper)Hailin Tang (1 shared paper)Yanan Kong (1 shared paper)Feng Ye (1 shared paper)Lu Yang (1 shared paper)Xinhua Xie (1 shared paper)Neng Wang (1 shared paper)
- Journals
- Cell Death and Differentiation (1 paper)Journal of Pharmacological Sciences (1 paper)Medicine (1 paper)Journal of Translational Medicine (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jianping Chen
19 papers receiving 415 citations
Peers
Comparison fields: 5 of 68
- Oncology 182
- Cancer Research 66
- Molecular Biology 213
- Immunology 60
- Pharmacology 15
Countries citing papers authored by Jianping Chen
This map shows the geographic impact of Jianping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Chen more than expected).
Fields of papers citing papers by Jianping Chen
This network shows the impact of papers produced by Jianping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Chen. The network helps show where Jianping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 137 | |
| 2 | 2012 | 42 | |
| 3 | 2018 | 39 | |
| 4 | 2016 | 36 | |
| 5 | Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models. | 1999 | 31 |
| 6 | 2006 | 21 | |
| 7 | Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer. | 2014 | 21 |
| 8 | 2015 | 14 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 13 | |
| 11 | 2008 | 10 | |
| 12 | 2021 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2015 | 6 | |
| 17 | 2008 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2008 | 2 | |
| 20 | 2025 | 0 |
About Jianping Chen
Jianping Chen is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Surgery, having authored 20 papers that have together received 422 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Cancer-related Molecular Pathways (2 papers), Immune Cell Function and Interaction (2 papers), HER2/EGFR in Cancer Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Heat shock proteins research (1 paper) and Wound Healing and Treatments (1 paper). The work is most often cited by research in Oncology (182 citations), Cancer Research (66 citations), Molecular Biology (213 citations), Immunology (60 citations) and Pharmacology (15 citations). Jianping Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiaoping Liu, Ning Li, Hailin Tang, Yanan Kong, Feng Ye, Lu Yang, Xinhua Xie, Neng Wang, Cailu Song and Xiaoming Xie. Their work appears in journals such as Cell Death and Differentiation, Journal of Pharmacological Sciences, Medicine, Journal of Translational Medicine and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.